Inari Medical Q2 Sales $146.00M Beat $143.75M Estimate
Portfolio Pulse from Benzinga Newsdesk
Inari Medical (NASDAQ:NARI) reported Q2 sales of $146.00 million, surpassing the analyst consensus estimate of $143.75 million by 1.57%. This represents a 22.68% increase from the same period last year.
July 30, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inari Medical reported Q2 sales of $146.00 million, beating the analyst consensus estimate of $143.75 million by 1.57%. This marks a 22.68% increase from the same period last year.
Inari Medical's Q2 sales exceeded expectations and showed significant year-over-year growth, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100